Related Experiment Video
Updated: Jul 14, 2026

07:16
High-resolution Tandem Mass Spectrometry for Studying Chemical Constituents of Gynura bicolor DC
Published on: February 2, 2024
[Phytochemical investigation on Lysimachia fortunei].
Xin-An Huang1, Jia-Zhong Cai, Ying-Jie Hu
1Pharmacy Laboratory, Tropical Medicine Institute, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405, China. xahuang@163.net
Summary
Nine chemical compounds were identified from the ethyl acetate extract of Lysimachia fortunei. This study marks the first isolation of these compounds from this plant and some from the Lysimachia genus.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
- Organic Chemistry
Background:
- Lysimachia fortunei is a plant with traditional medicinal uses.
- Investigating its chemical constituents can reveal novel bioactive compounds.
- Understanding the chemical profile is crucial for pharmacological research.
Purpose of the Study:
- To isolate and identify the chemical constituents present in the ethyl acetate extract of Lysimachia fortunei.
- To contribute to the phytochemical knowledge of the Lysimachia genus.
Main Methods:
- Extraction of compounds from Lysimachia fortunei using ethyl acetate.
- Isolation of compounds via silica gel column chromatography.
- Structure elucidation using Nuclear Magnetic Resonance (NMR) spectroscopy and literature data.
Main Results:
- Nine natural compounds were successfully isolated and identified.
- Identified compounds include: 9,19-cyclolanost-24-en-3-one (1), 24-ethyl-5alpha-cholesta-7, 22(E)-dien-3-one (2), 1-pentatriacontanol (3), beta-stigmasterol (4), 24-ethyl-5alpha-cholesta-7, 22(E)-dien-3beta-ol (5), palmitic acid (6), isorhamnetin (7), kaempferol (8), and quercetin (9).
Conclusions:
- All nine identified compounds represent novel phytochemical findings for Lysimachia fortunei.
- Compounds 1, 2, and 5 are reported for the first time within the Lysimachia genus.
- This research expands the understanding of Lysimachia fortunei's chemical diversity.